The Her2/neu female transgenic mouse model is an excellent preclinical model for breast cancer prevention studies because the mice develop spontaneous ER-negative mammary cancer that resembles human pathogenesis [56, 57]. The gene discussed is ERBB2; the disease is breast carcinoma.